Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Allergen Biocube Study Evaluating Efficacy and Safety of Nasapaque Nasal Solution in Adult Subjects With Allergic Rhinitis
Phase 1
Completed
- Conditions
- Seasonal Allergic Rhinitis
- Interventions
- Drug: Placebo Saline Nasal SolutionDrug: Nasapaque Nasal Solution
- First Posted Date
- 2015-03-04
- Last Posted Date
- 2017-01-26
- Lead Sponsor
- 3E Therapeutics Corporation
- Target Recruit Count
- 73
- Registration Number
- NCT02377895
News
No news found